Inactive Instrument

Insiders KetamineOne Capital Deutsche Boerse AG

Equities

Wellbeing Digital Sciences Inc. Appoints Mohammad Sharifi to Board of Directors	22/11/22	CI
Wellbeing Digital Sciences Inc. Announces Management Changes	18/11/22	CI
Wellbeing Digital Sciences Inc. Appoints Najla Guthrie to the Benzinga Psychedelic Advisory Council	30/08/22	CI
Wellbeing Digital Sciences Appoints Natalie Dolphin as VP of Marketing and Investment Relations	21/06/22	CI
Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial Officer	15/06/22	CI
Wellbeing Digital Sciences Inc. Announces Resignation Joseph Ramelli as Chief Financial Officer	27/05/22	CI
Wellbeing Digital Sciences Inc. Appoints Michael Ho as the New Medical Director, Effective May 2, 2022	03/05/22	CI
Wellbeing Digital Sciences Announces CEO Changes, Effective March 31, 2022	07/03/22	CI
KetamineOne Capital Limited has Changed its Name to Wellbeing Digital Sciences Inc	24/01/22	CI
KetamineOne Capital Limited Announces Management Appointments	05/01/22	CI
KetamineOne Capital Limited Announces Departure of Mark Kimmins as Chief Medical Officer	16/12/21	CI
KetamineOne Capital Limited Appoints Joe Ramelli as Its New Chief Financial Officer	14/12/21	CI
Ketamine One Announces Resignation of Loreto Grimaldi from Board of Directors	04/11/21	CI
Auralite Investments Inc. Announces Management Changes	29/01/19	CI
Auralite Investments Inc. Announces Management Changes	19/12/18	CI
Cabernet Capital Corp. has Changed its Name to Auralite Investments Inc	07/09/18	CI

No results for this search